Analysis

M&A trends in life sciences and health care

Growth at the global intersection of change

Findings from survey of 240+ senior life sciences and health care executives for their insights into the forces underlying the current M&A trends in the life sciences and health care industry.

Explore content

What drives M&A in the industry?

Pharmaceutical firms, health care companies and other life science enterprises are increasingly expanding into new markets in their search for growth, driven by a combination of shrinking pipelines, more rigorous regulatory scrutiny, patent expirations, and competition from generic manufacturers. While high-profile M&A deals have grabbed headlines, some of the more subtle aspects of this expansion are less understood.
The Economist Intelligence Unit, in collaboration with Deloitte, surveyed 240+ senior life sciences and health care executives for their insights into the forces underlying the current M&A trends in the life sciences and health care industry. 

(2.8MB, PDF)
Did you find this useful?